Childhood cancers: open trials in Israel

44 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC
Carmel Medical Center, Haifa · Hadassah University Hospita Ein Kerem, Jerusalem · Sheba medical center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-11-04
NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Sheba Medical Center-Institute of Endocrinology, Diabetes and Metabolism (Site 1400), Ramat Gan · Sourasky Medical Center (Site 1401), Tel Aviv
Registry updated 2026-11-03
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Soroka Medical Center, Beersheba · Hadassah Medical Center - Ein Kerem Hospital, Jerusalem · Tel-Aviv Sourasky Medical Center, Tel Aviv · The Chaim Sheba Medical Center, Tel-Hashomer
Registry updated 2026-11-02
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus-Pediatric Hemato-Oncology (Site 1674), Haifa · Sheba Medical Center (Site 1675), Ramat Gan
Registry updated 2026-10-30
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Rambam Health Care Campus (Site 0903), Haifa · Haddasah Medical Center (Site 0900), Jerusalem · Sheba Medical Center (Site 0902), Ramat Gan · Sourasky Medical Center. (Site 0904), Tel Aviv
Registry updated 2026-10-30
NCT07630974
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus (Site 4674), Haifa · Schneider Children's Medical Center (Site 4676), Petah Tikva · Sheba Medical Center (Site 4675), Ramat Gan
Registry updated 2026-10-30
NCT05376891
Met Non Small Cell Cancer Registry (MOMENT)
Research · EMD Serono Research & Development Institute, Inc.
Haemek Medical Center, Afula · Carmel Medical Center, Haifa · Bnei-Zion Medical Center, Haifa · Rambam Medical Center - PPDS, Haifa · Shaare Zedek Medical Center, Jerusalem · Rabin Medical Center Oncology Beilinson Campus, Petah Tikva · Chaim Sheba Medical Center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-10-29
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Tel Aviv Sourasky Medical Centre Dana-Dwek Children's Hospital, Tel Aviv
Registry updated 2026-10-26
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Haifa · Jerusalem · Petah Tikva · Tel Aviv · Tel HaShomer
Registry updated 2026-10-21
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Schneider Childrens Medical Center, Petah Tikva
Registry updated 2026-10-19
NCT07387926
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Ramat Gan
Registry updated 2026-10-15
NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Trial Treatment · Phase 1/2 · Syndax Pharmaceuticals
Rambam Health Care Campus (RHCC), Haifa · Shaare Zedek Medical Center, Jerusalem · Hadassah Medical Center - Ein Kerem, Jerusalem · Galilee Medical Center, Nahariya · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan
Registry updated 2026-10-09
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Soroka Medical Center, Beersheba · Rabin Medical Center, Petah Tikva · Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Ramat Gan · Tel Aviv Medical Center, Tel Aviv
Registry updated 2026-10-06
NCT06941272
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus (Site 3674), Haifa · Sheba Medical Center (Site 3675), Ramat Gan
Registry updated 2026-10-06
NCT07602777
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Jerusalem · Tel Aviv
Registry updated 2026-10-01
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
Rambam Health Care Campus, Haifa · Schneider Children's Medical Center, Petah Tikva · The Edmond and Lily Safra Children's Hospital; The Chaim Sheba Medical Center, Ramat Gan · Tel-Aviv Sourasky Medical Center Dana-Dwek Children's Hospital, Tel Aviv
Registry updated 2026-09-24
NCT05041309
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Research · Phase 2 · Kite, A Gilead Company
Tel Aviv Souraski Medical Center, Tel Aviv
Registry updated 2026-09-21
NCT07537400
Patients Between the Ages of 12 Months to 21 Years With Newly-Diagnosed High-Risk Neuroblastoma Will Receive Children's Oncology Group (COG) Type Recommended Therapy With the Addition of Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) to Induction Cycles 1-5
Trial Treatment · Phase 2 · Shaare Zedek Medical Center
Shaare Zedek Medical Center, Jerusalem
Registry updated 2026-09-17
NCT06651580
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Research · M.D. Anderson Cancer Center
Hadassah University Hospital, Jerusalem
Registry updated 2026-09-11
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Rambam Medical Center, Haifa · Schneider Children's Medical Center of Israel, Petah Tikva · Dana Children's Hospital, Tel Aviv
Registry updated 2026-09-04
NCT07196644
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
Trial Treatment · Phase 2 · AbbVie
Hadassah Medical Center-Hebrew University /ID# 274343, Jerusalem · Rabin Medical Center. /ID# 274341, Petah Tikva · The Chaim Sheba Medical Center /ID# 274342, Ramat Gan · Tel Aviv Sourasky Medical Center /ID# 274344, Tel Aviv
Registry updated 2026-08-14
NCT05697874
International Rare Brain Tumor Registry
Research · Children's National Research Institute
Rambam Health Care Campus, Haifa · Schneider Children's Medical Center- CLALIT Health Services, Petah Tikva · Dana-Dwek Children's Hospital- Tel Aviv Medical Center, Tel Aviv · The Sheba Medical Center, Tel HaShomer
Registry updated 2026-08-07
NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Merck Sharp & Dohme Co. Ltd., Hod HaSharon
Registry updated 2026-07-06
NCT05009992
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Trial Treatment · Phase 2 · University of California, San Francisco
Shaare Zedek Medical Center, Jerusalem · Sheba medical center, Tel HaShomer
Registry updated 2026-06-26
NCT04043494
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Trial Treatment · Phase 3 · University Hospital Muenster
Children's Hospital at Soroka Medical Center, Beersheba · Ruth Rappaport Children's Hospital, Rambam Medical Center, Haifa · Children's Hospital at Hadassah, Ein Kerem Medical Center, Jerusalem · Schneider Children's hospital, Rabin Medical Center, Petah Tikva · Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan · Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-05-06

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error